Omega-3s after 40: sorting evidence from marketing

The short answer: omega-3s have one clearly proven effect — at pharmaceutical doses of 2–4 g/day of EPA plus DHA, they have been shown to lower blood triglycerides substantially. Everything else is weaker than the bottle suggests. General-population trials of typical supplement doses (around 1 g/day) have not reduced heart attacks or deaths in already well-fed populations. Eating two servings of oily fish a week covers most of what the evidence supports, and does it better than capsules.

What it is

“Omega-3” covers three fatty acids that get treated as one thing and are not.

ALA (alpha-linolenic acid) is the plant form — flaxseed, chia, walnuts, canola. It is the only truly essential one, meaning your body cannot make it. The adequate intake is about 1.6 g/day for men and 1.1 g/day for women, which most people meet without trying.

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the marine forms — oily fish, and the algae the fish eat. These are what nearly all the outcome research studied, and what supplement marketing means when it says omega-3.

The catch that matters most: your body converts ALA to EPA and DHA very poorly. Conversion to EPA runs somewhere around 5–8%, and to DHA typically under 4% and often under 1%. Eating flaxseed is not a substitute for eating fish, and no amount of walnuts reliably raises DHA. This is the single most useful fact in the category, and the one most often glossed over.

EPA and DHA are incorporated into cell membranes throughout the body, concentrating in the brain and retina, and serve as precursors to signaling molecules involved in inflammation resolution and blood clotting. That mechanism is why omega-3s have been tested for almost everything — and why plausibility has repeatedly outrun results.

How much, and where from

There is no official RDA for EPA and DHA. The practical benchmark used in dietary guidance is roughly 250 mg/day of combined EPA and DHA, which is what two servings of oily fish a week works out to — about 8 ounces (230 g) total.

Rough content per typical serving:

Source	EPA + DHA per 3 oz (85 g)
Salmon, Atlantic farmed	~1,200–1,800 mg
Mackerel (Atlantic)	~1,000 mg
Sardines, canned	~800–1,000 mg
Herring	~1,700 mg
Trout, rainbow	~600–1,000 mg
Tuna, canned light	~200–250 mg
Cod	~130 mg
Shrimp	~250 mg

Two salmon or sardine meals a week put you comfortably past the benchmark. If you eat fish regularly, a supplement adds little.

What the evidence shows, graded

Has been shown to:

• Lower triglycerides. At 2–4 g/day of EPA+DHA, reductions of roughly 20–30% are consistent across many trials. This is the reason prescription omega-3 products exist, and it is dose-dependent — the 300 mg in a typical capsule does not do this.
• Raise blood and tissue omega-3 levels reliably, in a dose-dependent way.
• Modestly increase the risk of atrial fibrillation at higher doses. This is the finding the category does not advertise. Across several large trials and pooled analyses, doses of about 1 g/day and above have been associated with a small but consistent increase in new atrial fibrillation. Small absolute risk, real signal, worth knowing before you take 4 g a day on your own initiative.

Research suggests:

• A reduction in coronary heart disease events and cardiac death, concentrated in people who eat little fish at baseline. Trials in populations already eating fish and taking statins have mostly been null; trials in low-intake groups show more. The likely reading is that omega-3 corrects a shortfall rather than adding benefit on top of sufficiency — the same shape as the vitamin D story.
• Benefit in high-risk cardiovascular patients at high dose. One large trial of 4 g/day of a purified EPA-only prescription drug in statin-treated patients with elevated triglycerides found a substantial reduction in cardiovascular events. A comparable trial of a mixed EPA/DHA formulation found nothing. Whether the difference is EPA versus DHA, the dose, or the comparator oil used is genuinely unresolved.
• Reduced joint tenderness and lower NSAID use in rheumatoid arthritis, at doses around 2–3 g/day. One of the more durable non-cardiac findings.
• Lower blood pressure, by a small amount — on the order of 1–3 mmHg at higher doses.

May help, evidence early or mixed:

• Depression, as an adjunct to treatment, with EPA-predominant formulations at 1 g/day or more. Results are inconsistent and the better-controlled trials are less impressive than the earlier ones.
• Cognitive decline and dementia prevention. Observational data look encouraging; randomized trials in older adults have largely been null.
• Dry eye disease. A large well-run trial found no benefit over placebo, against earlier positive but smaller studies.
• Muscle preservation and response to training in older adults. Interesting early mechanistic work, small trials, not enough to act on.
• Age-related macular degeneration progression. Trials have not shown benefit despite strong biological rationale.

Who it may suit

• People who don’t eat fish. If oily fish appears on your plate rarely or never, a supplement is a reasonable way to reach the 250–500 mg/day range. This is the clearest case.
• People with elevated triglycerides, where dose matters and this should be a clinician-directed decision rather than a self-prescribed one.
• Vegetarians and vegans, for whom algal oil is the direct source — it’s where fish get theirs, and it skips the conversion problem entirely.
• People with established cardiovascular disease and high triglycerides, under medical supervision, where prescription-strength formulations have a defined role.

For a healthy adult over 40 who eats fish twice a week, adding a supplement is unlikely to change anything measurable.

Who should ask a clinician first

• Anyone taking anticoagulants or antiplatelet drugs — warfarin, direct oral anticoagulants, clopidogrel, or daily aspirin. Clinically significant bleeding at typical doses appears less common than once feared, but at high doses and in combination it warrants a conversation rather than an assumption.
• Anyone scheduled for surgery. Ask whether and when to stop.
• Anyone with a history of atrial fibrillation, given the dose-related signal above.
• Anyone with a fish or shellfish allergy. Highly refined fish oil is often tolerated, but this is not a decision to make alone; algal oil avoids the question.
• During pregnancy or breastfeeding. DHA matters for fetal brain development and intake is often low, but fish choice matters for mercury — avoid shark, swordfish, king mackerel, and tilefish, and get the supplement decision confirmed rather than guessed.
• Anyone on blood pressure medication, since the effects add.
• Anyone considering more than about 3 g/day from supplements, which is above the range regulators consider clearly safe for unsupervised use.

What to look for in a product

Generic criteria only:

• The EPA and DHA numbers, not the fish oil number. A “1,000 mg fish oil” capsule commonly contains around 300 mg of combined EPA+DHA. The rest is other fats. This is the most consequential label trick in the category.
• The serving size. Check whether the front-of-bottle dose refers to one capsule or three. It is often three.
• Third-party testing — IFOS, NSF, USP, or an equivalent independent program — covering both potency and contaminants (mercury, PCBs, dioxins). Purification removes most heavy metals from fish oil, but verification is the only way you know it happened for your bottle.
• Some indication of freshness or oxidation control. Omega-3s are chemically fragile and oxidize into rancid compounds. Look for an added antioxidant such as tocopherol, a stated peroxide or TOTOX value if the brand publishes one, an intact seal, and a distant expiry date. A strongly fishy smell on opening, or persistent fishy repeat, means oxidized oil — which is worth returning, not pushing through.
• A form that suits you. Triglyceride and re-esterified triglyceride forms are absorbed somewhat better than ethyl esters; ethyl esters are cheaper and work, especially taken with a fatty meal. The gap is smaller than the price difference implies.
• Algal oil if you avoid fish. It delivers DHA (and increasingly EPA) directly, is free of ocean contaminants, and is the sustainable option.
• Cool, dark storage. Refrigeration after opening slows oxidation.

What the marketing overstates

“Supports heart health.” For a healthy person already eating fish, the trials do not support it. That phrase survives because it’s legally permitted, not because it’s been demonstrated.

Brain and memory claims. DHA is structurally important in the brain. That is not the same as supplementation improving cognition in adults, which the randomized trials have generally failed to show.

Joint claims aimed at general aches. The decent evidence is in rheumatoid arthritis, an autoimmune disease, at doses well above what joint-support products contain. Extending it to ordinary osteoarthritis or post-exercise stiffness is a stretch.

Krill oil superiority. Phospholipid-bound omega-3 is absorbed efficiently, but krill capsules typically contain far less EPA+DHA per capsule and cost considerably more per milligram. On dose-for-dose grounds the premium is hard to justify.

Mega-dosing as obviously safer than under-dosing. More is not neutral here. The atrial fibrillation signal rises with dose, and the benefits above 1 g/day are confined to specific clinical situations.

“Anti-inflammatory” as a general promise. Omega-3s shift the balance of inflammatory signaling molecules — a measurable biochemical fact that has not translated into broad symptomatic benefit for most conditions tested.

When to talk to a clinician

Talk to your clinician before starting if you take anticoagulants or antiplatelet medication, have atrial fibrillation, have a fish allergy, are pregnant or breastfeeding, or are planning surgery.

Talk to them rather than self-treating if your triglycerides are elevated. The dose that lowers triglycerides is several times what over-the-counter capsules typically deliver, prescription formulations differ meaningfully from one another, and elevated triglycerides often signal something else worth addressing — alcohol intake, blood sugar control, thyroid function, or medication effects.

And if you’ve noticed new palpitations or an irregular heartbeat after starting a high-dose product, mention it. It may be unrelated. It’s worth saying out loud.